Pergolide mesylate (1 mg tablets), a dopamine receptor agonist for oral use in horses. This is the first and only FDA-approved treatment for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in horses. Do not use in horses intended for human consumption. May interfere with reproductive hormones and events in breeding, pregnant, or lactating horses.